142 related articles for article (PubMed ID: 17940629)
1. Bringing science to cancer therapy.
Mellman I
Yale J Biol Med; 2006 Dec; 79(3-4):177-8. PubMed ID: 17940629
[No Abstract] [Full Text] [Related]
2. Anticancer drug discovery and development.
Colotta F
Adv Exp Med Biol; 2008; 610():19-42. PubMed ID: 18593013
[No Abstract] [Full Text] [Related]
3. Targeted therapies in cancer: myth or reality? Introduction.
Colotta F; Mantovani A
Adv Exp Med Biol; 2008; 610():v-vi. PubMed ID: 18593010
[No Abstract] [Full Text] [Related]
4. Genetic testing in cancer therapeutics.
Ezzeldin HH; Diasio RB
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
[No Abstract] [Full Text] [Related]
5. [From psychooncological research to clinical practice].
Schwarz R; Weis J; Riedel S
Onkologie; 2004 Apr; 27(2):213. PubMed ID: 15143775
[No Abstract] [Full Text] [Related]
6. Abstracts of the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. October 22-26, 2007. San Francisco, California, USA.
Mol Cancer Ther; 2007 Dec; 6(12 Pt 2):3331s-704s. PubMed ID: 18300399
[No Abstract] [Full Text] [Related]
7. Precision oncology: an overview.
Garraway LA; Verweij J; Ballman KV
J Clin Oncol; 2013 May; 31(15):1803-5. PubMed ID: 23589545
[No Abstract] [Full Text] [Related]
8. International Symposium on Biology of Cancer Prevention and Treatment: meeting report.
Mihich E; Tominaga S; Zanker KS; Zhang Y
Int J Cancer; 2000 Aug; 87(3):457-60. PubMed ID: 10897056
[No Abstract] [Full Text] [Related]
9. Cancer care expands to include genetic testing.
Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
[No Abstract] [Full Text] [Related]
10. Ligand-based vascular targeting of disease.
Rybak JN; Trachsel E; Scheuermann J; Neri D
ChemMedChem; 2007 Jan; 2(1):22-40. PubMed ID: 17154429
[TBL] [Abstract][Full Text] [Related]
11. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
12. Beyond VEGF: targeting tumor growth and angiogenesis via alternative mechanisms.
Christensen J; Anderes K
Adv Exp Med Biol; 2008; 610():43-53. PubMed ID: 18593014
[No Abstract] [Full Text] [Related]
13. The Signature Program: Bringing the Protocol to the Patient.
Kang BP; Slosberg E; Snodgrass S; Lebedinsky C; Berry DA; Corless CL; Stein S; Salvado A
Clin Pharmacol Ther; 2015 Aug; 98(2):124-6. PubMed ID: 25810246
[TBL] [Abstract][Full Text] [Related]
14. A radical rethinking of treatment. The aim is to make cancer curable or a manageable chronic disease.
Hobson K
US News World Rep; 2008 Nov 3-10; 145(10):48-50, 53. PubMed ID: 18998442
[No Abstract] [Full Text] [Related]
15. New frontiers in molecular oncology.
Memo M; Vezzoni P; Spano P
Mol Med Today; 1995 Aug; 1(5):212-3. PubMed ID: 17607882
[No Abstract] [Full Text] [Related]
16. Searching for the answer to cancer: new perspective may help to resolve an ageless conundrum.
Watson RA
Urol Oncol; 2013 Aug; 31(6):721-6. PubMed ID: 23769267
[No Abstract] [Full Text] [Related]
17. The many challenges of veterinary oncology.
Kidd C
Can Vet J; 2008 Nov; 49(11):1132-5. PubMed ID: 19183739
[No Abstract] [Full Text] [Related]
18. Recent advances in medical oncology--1995-1996.
Sikov WM
Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
[No Abstract] [Full Text] [Related]
19. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
Scholler N
IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
[No Abstract] [Full Text] [Related]
20. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development.
Meyskens FL
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2038-41. PubMed ID: 17119025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
